Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
People's Liberation Army 263 Hospital, Beijing, China.
Clin Microbiol Infect. 2020 Feb;26(2):213-219. doi: 10.1016/j.cmi.2019.07.015. Epub 2019 Jul 20.
Tuberculous meningitis (TBM) is difficult to diagnose. Digital PCR (dPCR) is a novel method which can quantify trace nucleic acids. This study sought to evaluate the diagnostic accuracy of dPCR analysis of cerebrospinal fluid (CSF) for TBM.
We collected CSF specimens from hospitalized TBM and non-TBM patients. Total CSF DNA was purified and the concentrations of Mycobacterium tuberculosis insert sequence 6110 (IS6110) and gyrase subunit B (gyrB) were quantified using droplet dPCR. The receiver operating characteristic curves of dPCR were established and the diagnostic performances were obtained. We also compared the sensitivity of dPCR with routine diagnostic tests.
A total of 101 patients were recruited, 68 of whom suffered from TBM (26 definite, 34 probable and eight possible TBM) and 33 from non-TBM. The sensitivity of IS6110-dPCR assay for total TBM was higher than that of gyrB-dPCR assay (57.4% (44.8-69.3%) vs. 22.1% (12.9-33.8%)), and there was no significant difference for specificity between them (97.0% (84.2-99.9%) vs. 100% (89.4-100.0%)). The sensitivity of IS6110-dPCR in definite TBM was higher than that in probable and possible TBM (73.1% vs. 52.9% and 25.0%, respectively). IS6110-dPCR assay showed a higher sensitivity than smear microscopy (53.3% vs. 6.7%), mycobacterial culture (50.0% vs. 12.5%), IS6110-quantitative PCR (53.1% vs. 21.9%) and Xpert MTB/RIF (70.4% vs. 29.6%). Long anti-tuberculosis treatment time was found to be significantly associated with negative dPCR results.
CSF IS6110-dPCR assay is a rapid and sensitive molecular test, which has the potential to be used to enhance the diagnosis of TBM.
结核性脑膜炎(TBM)的诊断较为困难。数字 PCR(dPCR)是一种新型的痕量核酸定量方法。本研究旨在评估脑脊液(CSF)中 dPCR 分析结核分枝杆菌(Mtb)插入序列 6110(IS6110)和拓扑异构酶 II 亚基 B(gyrB)的诊断准确性。
我们收集了住院 TBM 和非 TBM 患者的 CSF 标本。纯化总 CSF DNA,采用液滴式 dPCR 定量检测 Mtb IS6110 和 gyrB。建立 dPCR 的受试者工作特征曲线,得出诊断性能。我们还比较了 dPCR 与常规诊断检测的敏感性。
共纳入 101 例患者,其中 68 例为 TBM(26 例确诊、34 例可能和 8 例可疑),33 例为非 TBM。IS6110-dPCR 检测总 TBM 的敏感性高于 gyrB-dPCR 检测(57.4%(44.8-69.3%)比 22.1%(12.9-33.8%)),特异性无显著差异(97.0%(84.2-99.9%)比 100%(89.4-100.0%))。IS6110-dPCR 在确诊 TBM 中的敏感性高于可能和可疑 TBM(73.1%比 52.9%和 25.0%)。IS6110-dPCR 检测的敏感性高于涂片显微镜检查(53.3%比 6.7%)、分枝杆菌培养(50.0%比 12.5%)、IS6110-定量 PCR(53.1%比 21.9%)和 Xpert MTB/RIF(70.4%比 29.6%)。较长的抗结核治疗时间与 dPCR 阴性结果显著相关。
CSF IS6110-dPCR 检测是一种快速、敏感的分子检测方法,有望用于提高 TBM 的诊断率。